Bothell, Wash-based Ventec Life Systems has received 510(k) clearance from the FDA for its VOCSN portable respiratory device for patients on a ventilator.
VOCSN is designed to work in hospital, institutional, transport, and home environments for patients with neuromuscular disease, impaired lung function, spinal cord injury, and pediatric development complication.
According to the company in a media release, VOCSN is reportedly the only portable life support device that combines five respiratory therapies—ventilation, oxygen, cough, suction, and nebulization—in one. Patients can personalize their device to receive all five therapies or just the mix of therapies needed.
Additional features include a small and light size, a 9-hour on-board battery, and control via an intuitive touchscreen and a user-friendly operating system that allows therapies to be switched with the touch of a button rather than changing the patient circuit, the release adds.
“I’ve seen firsthand how improved ventilator technology can enhance the quality of life for patients and caregivers. Our team didn’t want to create just another ventilator, we spent the past five years focused on building a truly integrated solution,” says Doug DeVries, founder and chief executive officer at Ventec Life Systems, in the release.
A limited number of VOCSN devices will ship in the United States beginning in June 2017, Asia in 2017, and Canada and Europe in 2018, the company notes.
[Source(s): Ventec Life Systems, Business Wire]
